Où achat cialis sans ordonnance et acheter viagra en France.
DUPONT REPORTS FIRST QUARTER
• First quarter 2003 earnings, before special items and cumulative effect of changes in accounting
principles, were $.61 per share compared with first quarter 2002 earnings of $.55, up
• First quarter 2003 income before cumulative effect of changes in accounting principles was
$564 million, or $.56 per share, compared with $479 million, or $.48 per share, for the first
• Consolidated net sales for the first quarter were $7 billion, up 14 percent, driven by a 7 percent
volume increase and a 6 percent benefit from the currency effect of a weaker U.S. dollar.
Excludes cumulative effect of changes in accounting principles of $(.03)in 2003 and $(2.94) in 2002.
"Our sales growth in the first quarter reflects strong volume increases in each of our five
growth platforms and DuPont Textiles & Interiors (DTI). This broad-based volume growth, combined
with particularly strong results in Pharmaceuticals, Agriculture & Nutrition and Safety & Protection,
offset the impact of higher pension, energy, and raw material costs in the first quarter," said Charles O.
Holliday, Jr., chairman and CEO. "Our businesses performed well, maintaining their momentum even
better than expected through the end of the quarter."
Global Consolidated Net Sales and Net Income
Consolidated net sales totaled $7 billion compared to $6.1 billion in first quarter 2002, up
14 percent. This includes 7 percent higher sales volume, a 2 percent benefit attributable to the net impact
of acquired and divested businesses, and a 6 percent benefit from the weaker dollar, partly offset by
1 percent lower local selling prices.
First quarter net income was $535 million, compared to a loss of $2,465 million in the
first quarter of 2002. Income before cumulative effect of changes in accounting principles was
$564 million in the current quarter versus $479 million in the first quarter 2002, up 18 percent. The
increase in income principally reflects higher sales volumes, the benefit of a weaker U.S. dollar and lower
income taxes, partly offset by increases in raw material costs and pension expense.
Special items, which are described in the notes accompanying the financial statements,
totaled an after-tax charge of $51 million, or $.05 per share, in the first quarter 2003 versus a net after-tax
charge of $73 million, or $.07 per share, last year, as shown in the table below:
($ Per Share)
Benlate Shareholder Litigation Settlement
First Quarter Segment Sales
Worldwide and regional segment sales and related variances for the first quarter 2003
compared with the first quarter 2002 are summarized below. Segment sales include transfers and a pro
rata share of equity affiliate sales.
% Change Due To
Net impact of acquisitions and divestitures and a change in management reporting for certain
• Volumes increased in all segments and regions.
• U.S. sales increased 8 percent including 3 percent volume growth and a 3 percent benefit from the net
impact of acquisitions and divestitures.
• European sales increased 24 percent on 8 percent higher volume, and 16 percent higher U.S. dollar
• Asia Pacific sales were up 25 percent reflecting 22 percent higher volume due to continued strength
Business Segment Performance
Summarized below are comments on individual segment sales and after-tax operating
income (ATOI) for the first quarter 2003 compared with the first quarter 2002. All segments had a
benefit to sales ranging from 5-8 percent resulting from the currency effect of the weaker dollar.
Additional segment information is available to investors and the public via the earnings data section of the
• Agriculture & Nutrition -
Sales of $1.8 billion increased 11 percent reflecting 5 percent higher U.S.
dollar selling prices, 4 percent higher volume, and a 2 percent benefit from the acquisition of Liqui-Box. ATOI was $378 million versus $323 million, up 17 percent, principally reflecting higher salesof production agriculture products, partly offset by the negative impact of higher non-cash pensionexpense.
• Coatings & Color Technologies -
Sales of $1.3 billion were up 12 percent reflecting 5 percent
higher volume and 7 percent higher U.S. dollar selling prices. ATOI declined 13 percent to$74 million primarily due to higher TiO2 raw material costs in addition to higher non-cash pensionexpense.
• Electronic & Communication Technologies -
Sales of $0.7 billion were up 17 percent, principally
reflecting higher sales volumes, as U.S. dollar prices were flat. ATOI was $21 million versus$45 million last year. Earnings declined due to increased R&D and start-up costs for DisplaysTechnologies, as well as higher non-cash pension expense.
• Performance Materials -
Sales of $1.3 billion were up 15 percent due to 12 percent higher volume,
4 percent higher U.S. dollar selling prices, and a 1 percent reduction due to the divestiture of theDuPont Clysar shrink film business. ATOI of $75 million was 11 percent lower due to higherraw material and non-cash pension costs.
• Pharmaceuticals -
ATOI of $95 million was up 86 percent over prior year ATOI of $51 million. A
substantial portion of the increase is attributable to earnings related to a wholesaler buy-in inanticipation of a price increase for Cozaar/Hyzaar. Cozaar/Hyzaar continue to show solidgrowth globally, driven in part by new indications.
• Safety & Protection -
Sales of $1 billion were up 19 percent due to higher volumes, the acquisition
of ChemFirst, and higher U.S. dollar selling prices. ATOI increased 24 percent to $128 milliondespite higher non-cash pension expense, reflecting higher earnings from nonwoven and aramidproducts.
• Textiles & Interiors (DTI) -
Sales of $1.7 billion reflect 5 percent higher volume and 6 percent
higher U.S. dollar selling prices. In addition, in preparation for the planned separation of DTI, thecompany changed its management reporting regarding intermediates supplied to PerformanceMaterials to reflect market-based transfers. This change increased first quarter 2003 segment sales by8 percent versus prior year. ATOI was a loss of $5 million. First quarter 2002 ATOI of $20 million
included a net charge of $10 million for special items. The earnings decline principally reflects lowermargins due to higher raw material and non-cash pension costs.
Although the company currently expects the global economic recovery to resume its
moderate pace later in 2003, the near-term economic outlook is somewhat restrained -- particularly for
industrial production in developed economies. In addition, for the second quarter 2003 versus the prior
• The company expects significantly higher energy related raw material costs. The year over year
negative impact in the second quarter is expected to be at least double what it was in the first quarterof 2003.
• As previously announced, the company will incur higher non-cash expense in 2003, mainly related to
pension. This will negatively affect earnings per share versus the prior year by approximately10 cents per quarter throughout 2003.
Despite these challenges, the company expects its businesses to continue to perform well
in the market place, driving both volume growth and price increases. Taking all of these factors into
account, the company expects to deliver earnings per share for the first half of 2003 that are in line with
the current First Call earnings estimate consensus of $1.16 (which excludes the impact of DuPont’s first
quarter special item and cumulative effect of a change in accounting principle), yielding a second quarter
earnings outlook in the mid- to high 50 cents per share range. This outlook does not reflect any special
"Our leadership fully understands the near term challenges -- slower economic growth
and higher costs," said Holliday. "Our businesses are focused on what they can control, keeping a tight
rein on cash costs and driving sales and volume growth by staying close to the customer. I am confident
that we will continue to outperform our competition."
DuPont is a science company. Founded in 1802, DuPont puts science to work by solving
problems and creating solutions that make people's lives better, safer and easier. Operating in more than
70 countries, the company offers a wide range of products and services to markets including agriculture,
nutrition, electronics, communications, safety and protection, home and construction, transportation and
Use of Non-GAAP Measures
Management believes that earnings before special items, a "non-GAAP" measure, is
meaningful to investors because it provides insight with respect to ongoing operating results of the
company. Special items represent significant charges or credits that are important to an understanding of
the company's ongoing operations. Such measurements are not recognized in accordance with generally
accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of
This news release contains forward-looking statements based on
management's current expectations, estimates and projections. All statements that address expectations or
projections about the future, including statements about the company's strategy for growth, product
development, market position, expected expenditures and financial results are forward-looking
statements. Some of the forward-looking statements may be identified by words like "expects,"
"anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are
not guarantees of future performance and involve a number of risks, uncertainties and assumptions.
Many factors, including those discussed more fully elsewhere in this release and in documents filed with
the Securities and Exchange Commission by DuPont, particularly its latest annual report on Form 10-K
and quarterly report on Form 10-Q, as well as others, could cause results to differ materially from those
stated. These factors include, but are not limited to changes in the laws, regulations, policies and
economic conditions, including inflation, interest and foreign currency exchange rates, of countries in
which the company does business; competitive pressures; successful integration of structural changes,
including restructuring plans, acquisitions, divestitures and alliances; cost of raw materials, research and
development of new products, including regulatory approval and market acceptance; and seasonality of
sales of agricultural products.
DuPont, Benlate, Clysar, Cozaar and Hyzaar are a trademark and registered trademarksof E.I. du Pont de Nemours and Company.
DECISION Sanofi-Aventis v. Russ Johnson c/o NetWeb, Inc. Complainant is Sanofi-Aventis , (“Complainant”) represented by Baila H. Celedonia, of Cowan, Liebowitz & Latman, P.C. , 1133 Avenue of the Americas, New York, NY 10036. Respondent is Russ Johnson c/o NetWeb, Inc. (“Respondent”), 206 S. Port Bass, Fair Play, SC 29643. REGISTRAR AND DISPUTED DOMAIN NAME The
Psychopharmacology (2001) 154:61–69DOI 10.1007/s002130000603 Tilman Schulte · Eva M. Müller-Oehring Hans Strasburger · Heinz Warzel · Bernhard A. Sabel Acute effects of alcohol on divided and covert attention in menReceived: 10 May 2000 / Accepted: 2 October 2000 / Published online: 21 December 2000© Springer-Verlag 2000 Abstract Rationale: While several studies identifiedaltered